Llwytho...
Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines
OBJECTIVES: Patients with highly resistant tuberculosis have few treatment options. Bedaquiline, pretomanid and linezolid regimen (BPaL) is a new regimen shown to have favourable outcomes after six months. We present an economic evaluation of introducing BPaL against the extensively drug-resistant t...
Prif Awduron: | , , , , , , , , , , , , , |
---|---|
Fformat: | Online Erthygl Texto |
Iaith: | English |
Cyhoeddwyd: |
BMJ Publishing Group
2021
|
Pynciau: | |
Mynediad Ar-lein: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647530/ https://www.ncbi.nlm.nih.gov/pubmed/34862287 http://dx.doi.org/10.1136/bmjopen-2021-051521 |